Stay updated on DCVax-L for Newly Diagnosed GBM Clinical Trial
Sign up to get notified when there's something new on the DCVax-L for Newly Diagnosed GBM Clinical Trial page.

Latest updates to the DCVax-L for Newly Diagnosed GBM Clinical Trial page
- Check5 days agoChange DetectedAdded revision: v3.4.3 and removed revision: v3.4.2.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page adds Revision: v3.4.2 and removes the funding-lapse notice along with the prior Revision: v3.4.1.SummaryDifference0.2%

- Check41 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check48 days agoChange DetectedShow glossary feature added; capitalization tweaks for update-related labels and a new revision indicator (v3.4.0) were introduced. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page shows a new revision entry (v3.3.4) and removal of the previous revision (v3.3.3). Core study information remains unchanged.SummaryDifference0.0%

- Check84 days agoChange DetectedNew recruitment sites across numerous US states and international locations were added. Several existing sites were removed.SummaryDifference2%

Stay in the know with updates to DCVax-L for Newly Diagnosed GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DCVax-L for Newly Diagnosed GBM Clinical Trial page.